Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

Table of Contents

February 2021; Volume 41,Issue 2

Reviews

  • You have access
    PARP Inhibitors in Prostate Cancer
    KABIR GREWAL, KAYANAAT GREWAL and IMAD A. TABBARA
    Anticancer Research February 2021, 41 (2) 551-556; DOI: https://doi.org/10.21873/anticanres.14807
  • You have access
    H19 in Endocrine System Tumours
    MAŁGORZATA ROLLA, ALEKSANDRA JAWIARCZYK-PRZYBYŁOWSKA, KATARZYNA KOLAČKOV and MAREK BOLANOWSKI
    Anticancer Research February 2021, 41 (2) 557-565; DOI: https://doi.org/10.21873/anticanres.14808
  • You have access
    Antiangiogenic Tyrosine Kinase Inhibitors in Metastatic Colorectal Cancer: Focusing on Regorafenib
    MARIOS PAPADIMITRIOU and CHRISTOS A. PAPADIMITRIOU
    Anticancer Research February 2021, 41 (2) 567-582; DOI: https://doi.org/10.21873/anticanres.14809

Experimental Studies

  • You have access
    Acquisition of Letrozole Resistance Through Activation of the p38/MAPK Signaling Cascade
    RASHIDRA R. WALKER, KAREN M. GALLEGOS, MELYSSA R. BRATTON, KITANI P. LEMIEUX, KUN ZHANG, GUANGDI WANG, A. MICHAEL DAVIDSON and SYREETA L. TILGHMAN
    Anticancer Research February 2021, 41 (2) 583-599; DOI: https://doi.org/10.21873/anticanres.14810
  • You have access
    The Acute Phase Protein Hepcidin Is Cytotoxic to Human and Mouse Myeloma Cells
    DAVID M. CONRAD, ASHLEY L. HILCHIE, KATELYN A.M. MCMILLAN, ROBERT S. LIWSKI, DAVID W. HOSKIN and MELANIE R. POWER COOMBS
    Anticancer Research February 2021, 41 (2) 601-608; DOI: https://doi.org/10.21873/anticanres.14811
  • You have access
    Tissue RNFT2 Expression Levels Are Associated With Peritoneal Recurrence and Poor Prognosis in Gastric Cancer
    MASAHIRO SASAHARA, MITSURO KANDA, DAI SHIMIZU, CHIE TANAKA, YOSHIKUNI INOKAWA, NORIFUMI HATTORI, MASAMICHI HAYASHI, GORO NAKAYAMA and YASUHIRO KODERA
    Anticancer Research February 2021, 41 (2) 609-617; DOI: https://doi.org/10.21873/anticanres.14812
  • You have access
    Inhibition of Invasion by Polyphenols from Citrus Fruit and Berries in Human Malignant Glioma Cells In Vitro
    HARCHARAN KAUR ROOPRAI, MARIA CHRISTIDOU, SAMANTHA ANGEL MURRAY, DEREK DAVIES, RICHARD SELWAY, RICHARD W. GULLAN and GEOFFREY J. PILKINGTON
    Anticancer Research February 2021, 41 (2) 619-633; DOI: https://doi.org/10.21873/anticanres.14813
  • You have access
    A Novel Orthotopic Mouse Model of Lung Metastasis Using Fluorescent Patient-derived Osteosarcoma Cells
    HIROMICHI OSHIRO, YASUNORI TOME, KENTARO MIYAKE, TAKASHI HIGUCHI, NORIHIKO SUGISAWA, JUN HO PARK, ZHIYING ZHANG, SAHAR RAZMJOOEI, FUMINORI KANAYA, KOTARO NISHIDA and ROBERT M. HOFFMAN
    Anticancer Research February 2021, 41 (2) 635-640; DOI: https://doi.org/10.21873/anticanres.14814
  • You have access
    Reversion from Methionine Addiction to Methionine Independence Results in Loss of Tumorigenic Potential of Highly-malignant Lung-cancer Cells
    JUN YAMAMOTO, YUSUKE AOKI, QINGHONG HAN, NORIHIKO SUGISAWA, YU SUN, KAZUYUKI HAMADA, HIROTO NISHINO, SACHIKO INUBUSHI, KENTARO MIYAKE, RYUSEI MATSUYAMA, MICHAEL BOUVET, ITARU ENDO and ROBERT M. HOFFMAN
    Anticancer Research February 2021, 41 (2) 641-643; DOI: https://doi.org/10.21873/anticanres.14815
  • You have access
    Urokinase-type Plasminogen Activator Is a Therapeutic Target for Overcoming Sorafenib Resistance in Hepatoma Cells
    MAMI OSAWA, YASUNOBU MATSUDA, YOSHIAKI KINOSHITA and TOSHIFUMI WAKAI
    Anticancer Research February 2021, 41 (2) 645-660; DOI: https://doi.org/10.21873/anticanres.14816
  • You have access
    Epithelial-to-mesenchymal Transition Heterogeneity of Circulating Tumor Cells and Their Correlation With MDSCs and Tregs in HER2-negative Metastatic Breast Cancer Patients
    MARIA A. PAPADAKI, DESPOINA AGGOURAKI, ELENI-KYRIAKI VETSIKA, NIKOLAOS XENIDIS, GALAKTEA KALLERGI, ATHANASIOS KOTSAKIS and VASSILIS GEORGOULIAS
    Anticancer Research February 2021, 41 (2) 661-670; DOI: https://doi.org/10.21873/anticanres.14817
  • You have access
    YYB-101, a Humanized Antihepatocyte Growth Factor Monoclonal Antibody, Inhibits Ovarian Cancer Cell Motility and Proliferation
    HYUN JUNG KIM and KYUN HEO
    Anticancer Research February 2021, 41 (2) 671-678; DOI: https://doi.org/10.21873/anticanres.14818
  • You have access
    Risk Assessment for Pathological Fracture After Bone Tumour Biopsy
    TADASHI IWAI, MANABU HOSHI, NAOTO OEBISU, KUMI ORITA, AKIYOSHI SHIMATANI, NAOKI TAKADA and HIROAKI NAKAMURA
    Anticancer Research February 2021, 41 (2) 679-686; DOI: https://doi.org/10.21873/anticanres.14819
  • You have access
    A Low Dose of Aripiprazole Has the Strongest Sensitization Effect Among 19 Repositioned Bipolar Drugs in P-gp-overexpressing Drug-resistant Cancer Cells
    CHUNXUE JIANG, SU HYUN LEE, JAE HYEON PARK, JIN-SOL LEE, JI WON PARK, JU RI KIM, SONG HEE LEE, HYUNG SIK KIM and SUNGPIL YOON
    Anticancer Research February 2021, 41 (2) 687-697; DOI: https://doi.org/10.21873/anticanres.14820
  • You have access
    CCL299, a Benzimidazole Derivative Induces G1 Phase Arrest and Apoptosis in Cancer Cells
    YOSHIFUMI OHNO, RUIRONG YI, AKIKO SUGANAMI, YUTAKA TAMURA, AKIO MATSUMOTO, SHOJI MATSUMOTO, KENGO SAITO and HIROSHI SHIRASAWA
    Anticancer Research February 2021, 41 (2) 699-706; DOI: https://doi.org/10.21873/anticanres.14821
  • You have access
    In Vitro Investigation of Jellyfish Collagen as a Tool in Cell Culture and (Bone) Tissue Engineering
    SAID ALKILDANI, OLE JUNG and MIKE BARBECK
    Anticancer Research February 2021, 41 (2) 707-717; DOI: https://doi.org/10.21873/anticanres.14822
  • You have access
    Influence of Canine Macrophage-derived Extracellular Vesicles on Apoptosis in Canine Melanoma and Osteosarcoma Cell Lines
    KYUNG-MI LEE, JU-HYUN AN, SE-JIN YANG, SU-MIN PARK, JEONG-HWA LEE, HYUNG-KYU CHAE, WOO-JIN SONG and HWA-YOUNG YOUN
    Anticancer Research February 2021, 41 (2) 719-730; DOI: https://doi.org/10.21873/anticanres.14823
  • You have access
    Anti-leukemic Activity of AIU2008 in FLT3-ITD-positive Acute Myeloid Leukemia
    HYO JEONG KIM, HWANI RYU, HYUN-KYUNG CHOI, JIE-YOUNG SONG, SANG-GU HWANG and JIYEON AHN
    Anticancer Research February 2021, 41 (2) 731-737; DOI: https://doi.org/10.21873/anticanres.14824
  • You have access
    Immunohistochemical Assessment of TNFAIP3/A20 Expression Correlates With Early Tumorigenesis in Breast Cancer
    FATEMEH SAHEB SHARIF-ASKARI, NOURA AL-KHAYYAL, IMAN TALAAT, NARJES SAHEB SHARIF-ASKARI, SURENDRA RAWAT, MAJD JUNDI, KARI SYRJÄNEN, RIFAT HAMOUDI and RIYAD BENDARDAF
    Anticancer Research February 2021, 41 (2) 739-745; DOI: https://doi.org/10.21873/anticanres.14825
  • You have access
    Lapathoside A Isolated from Fagopyrum esculentum Induces Apoptosis in Human Pancreatic Cancer Cells
    MI SOOK KANG, YOUNG-MIN HAM, DAE-JU OH, YONG-HWAN JUNG, SONG-I HAN and JAE HOON KIM
    Anticancer Research February 2021, 41 (2) 747-756; DOI: https://doi.org/10.21873/anticanres.14826
  • You have access
    Newly Synthesized DNA Methyltransferase Inhibitors as Radiosensitizers for Human Lung Cancer and Glioblastoma Cells
    CHAN WOO WEE, JIN HO KIM, HAK JAE KIM, HYUN-CHEOL KANG, SOO YOUN SUH, BEOM SOO SHIN, EUNSOOK MA and IL HAN KIM
    Anticancer Research February 2021, 41 (2) 757-764; DOI: https://doi.org/10.21873/anticanres.14827
  • You have access
    Salivary CPLANE1 Levels as a Biomarker of Oral Squamous Cell Carcinoma
    SEI UEDA, MITSUO GOTO, KENGO HASHIMOTO, MASAHIKO IMAZAWA, MARICO TAKAHASHI, ICHIRO OH-IWA, KAZUO SHIMOZATO, TORU NAGAO and SHUJI NOMOTO
    Anticancer Research February 2021, 41 (2) 765-772; DOI: https://doi.org/10.21873/anticanres.14828
  • You have access
    Optimization of an E1A Gene Expression Cassette in an Oncolytic Adenovirus for Efficient Tumor Cell Killing Activity
    FUMINORI SAKURAI, FUMITAKA NISHIMAE, KOSUKE TAKAYAMA and HIROYUKI MIZUGUCHI
    Anticancer Research February 2021, 41 (2) 773-782; DOI: https://doi.org/10.21873/anticanres.14829
  • You have access
    IL-8/CXCR2 Signalling Promotes Cell Proliferation in Oesophageal Squamous Cell Carcinoma and Correlates With Poor Prognosis
    MASAZUMI INOUE, HIROYA TAKEUCHI, SACHIKO MATSUDA, TOMOHIKO NISHI, KAZUMASA FUKUDA, RIEKO NAKAMURA, TSUNEHIRO TAKAHASHI, NORIHITO WADA, HIROFUMI KAWAKUBO and YUKO KITAGAWA
    Anticancer Research February 2021, 41 (2) 783-794; DOI: https://doi.org/10.21873/anticanres.14830
  • You have access
    Chloride Intracellular Channel Protein 1 (CLIC1), E-cadherin and P-cadherin Define Distinct Subclasses of HER2, Luminal B and Triple-negative Breast Cancer
    MARIUS RAICA, AMALIA RALUCA CEAUSU, ANCA MARIA CIMPEAN, ŞERBAN COMŞA and SIMONA SARB
    Anticancer Research February 2021, 41 (2) 795-802; DOI: https://doi.org/10.21873/anticanres.14831
  • You have access
    Prognostic Influence of Cytoplasmic/Nuclear Hepatoma-derived Growth Factor in Head and Neck Cancer
    HUAI-PAO LEE, KUO-WANG TSAI and CHING-CHIH LEE
    Anticancer Research February 2021, 41 (2) 803-810; DOI: https://doi.org/10.21873/anticanres.14832

Clinical Studies

  • You have access
    Serological Biomarker Test (GastroPanel®) in the Diagnosis of Functional Gastric Disorders, Helicobacter pylori and Atrophic Gastritis in Patients Examined for Dyspeptic Symptoms
    LEA PALOHEIMO, TAPANI TIUSANEN, OSMO SUOVANIEMI and KARI SYRJÄNEN
    Anticancer Research February 2021, 41 (2) 811-819; DOI: https://doi.org/10.21873/anticanres.14833
  • You have access
    Metformin Associates With Aggressive Features of Endometrial Cancer in Women With Type 2 Diabetes
    ELINA URPILAINEN, REETTA ARIMA, PEETER KARIHTALA, ULLA PUISTOLA and ANNE AHTIKOSKI
    Anticancer Research February 2021, 41 (2) 821-828; DOI: https://doi.org/10.21873/anticanres.14834
  • You have access
    Liquid Biopsy Cell-free DNA Biomarkers in Patients With Oligometastatic Colorectal Cancer Treated by Ablative Radiotherapy
    MASAKI NAKAMURA, SHUN-ICHIRO KAGEYAMA, MASAHIDE SEKI, AYAKO SUZUKI, MASAYUKI OKUMURA, HIDEHIRO HOJO, ATSUSHI MOTEGI and TETSUO AKIMOTO
    Anticancer Research February 2021, 41 (2) 829-834; DOI: https://doi.org/10.21873/anticanres.14835
  • You have access
    Determination of Deformable Image Registration Algorithms for Accumulating Dose in Carbon-ion Radiotherapy for Pancreatic Cancer
    YANG LI, YOSHIKI KUBOTA, MASAHIKO OKAMOTO, SHINTARO SHIBA, SHOHEI OKAZAKI, TOSHIAKI MATSUI, SHUNICHIRO KOMATSU and TATSUYA OHNO
    Anticancer Research February 2021, 41 (2) 835-843; DOI: https://doi.org/10.21873/anticanres.14836
  • You have access
    Biological and Clinicopathological Implications of Beta-3-N-acetylglucosaminyltransferase 8 in Triple-negative Breast Cancer
    MISATO OKAZAKI, KAORU MOGUSHI, KAORI DENDA-NAGAI, HARUHIKO FUJIHIRA, MIKI NOJI, KATRIN ISHII-SCHRADE, MADOKA SAKATA-MATSUZAWA, KATSUYA NAKAI, YOSHIYA HORIMOTO, MITSUE SAITO and TATSURO IRIMURA
    Anticancer Research February 2021, 41 (2) 845-858; DOI: https://doi.org/10.21873/anticanres.14837
  • You have access
    Potential Risk Factors Influencing the Formation of Postoperative Seroma After Breast Surgery – A Prospective Study
    JULIA UNGER, RICO RUTKOWSKI, THOMAS KOHLMANN, STEFAN PAEPKE, MAREK ZYGMUNT and RALF OHLINGER
    Anticancer Research February 2021, 41 (2) 859-867; DOI: https://doi.org/10.21873/anticanres.14838
  • You have access
    Evaluation of Serum Biomarker CEA and Ca-125 as Immunotherapy Response Predictors in Metastatic Non-small Cell Lung Cancer
    MAX R. CLEVERS, ELISABETH A. KASTELIJN, BAS J.M. PETERS, HANS KELDER and FRANZ M.N.H. SCHRAMEL
    Anticancer Research February 2021, 41 (2) 869-876; DOI: https://doi.org/10.21873/anticanres.14839
  • You have access
    Accelerated Fractionation Plus Chemotherapy Versus Conventionally Fractionated Radiochemotherapy for Unresectable Head-and-Neck Cancer
    DIRK RADES, CARLOS A. NARVAEZ, STEFAN JANSSEN, URSULA SCHRÖDER, KARL L. BRUCHHAGE, SAMER G. HAKIM, TOBIAS BARTSCHT and STEVEN E. SCHILD
    Anticancer Research February 2021, 41 (2) 877-884; DOI: https://doi.org/10.21873/anticanres.14840
  • You have access
    The Blood Microenvironment Influences the Molecular Phenotypes of Circulating Tumor Cells in Head and Neck Squamous Cell Carcinoma
    HIROE TADA, HIDEYUKI TAKAHASHI, SHOTA IDA, IKKO MITO, TOSHIYUKI MATSUYAMA and KAZUAKI CHIKAMATSU
    Anticancer Research February 2021, 41 (2) 885-893; DOI: https://doi.org/10.21873/anticanres.14841
  • You have access
    The Evaluation of the Malignant Characteristics of Conjunctival Lesions Based on the Dermatoscopic Algorithm
    MAGDALENA DĘBICKA-KUMELA, BOZENA ROMANOWSKA-DIXON, IZABELLA KARSKA-BASTA, JOANNA KOWAL and ANNA MARKIEWICZ
    Anticancer Research February 2021, 41 (2) 895-903; DOI: https://doi.org/10.21873/anticanres.14842
  • You have access
    Association Between CD133 Expression and Prognosis in Human Lung Adenocarcinoma
    NAOKI YAMASHITA, TSUNEHIRO OYAMA, TETSUYA SO, TAKEAKI MIYATA, TAKASHI YOSHIMATSU, RYUJI NAKANO, WATARU MATSUNAGA and AKINOBU GOTOH
    Anticancer Research February 2021, 41 (2) 905-910; DOI: https://doi.org/10.21873/anticanres.14843
  • You have access
    Phase Ib Study of Osimertinib Plus Ramucirumab in Japanese Lung Cancer Patients With EGFR Mutation
    HIROAKI AKAMATSU, YUICHI OZAWA, JUN OYANAGI, DAICHI FUJIMOTO, AKITO HATA, NOBUYUKI KATAKAMI, KEISUKE TOMII, ERIKO MURAKAMI, TAKEYA SUGIMOTO, TOSHIO SHIMOKAWA, YASUHIRO KOH and NOBUYUKI YAMAMOTO
    Anticancer Research February 2021, 41 (2) 911-917; DOI: https://doi.org/10.21873/anticanres.14844
  • You have access
    First Clinical Experience of Tungsten Rubber Electron Adaptive Therapy With Real-time Variable-shape Tungsten Rubber
    YOSHIHIRO KAWAI, MIKOTO TAMURA, MORIKAZU AMANO, TAKASHI KOSUGI and HAJIME MONZEN
    Anticancer Research February 2021, 41 (2) 919-925; DOI: https://doi.org/10.21873/anticanres.14845
  • You have access
    Adverse Events and Economic Burden Among Patients Receiving Systemic Treatment for Mantle Cell Lymphoma: A Real-World Retrospective Cohort Study
    SHAUM M. KABADI, STACEY DACOSTA BYFIELD, LISA LE and TEMITOPE OLUFADE
    Anticancer Research February 2021, 41 (2) 927-936; DOI: https://doi.org/10.21873/anticanres.14846
  • You have access
    Impact of a Province-wide Endometrial Cancer Guideline on Daily Practice
    VINCENZO DARIO MANDATO, FEDERICA TORRICELLI, VALENTINA MASTROFILIPPO, DEBORA PIRILLO, GIANLUCA ANNUNZIATA, GINO CIARLINI, GIOVANNI D’IPPOLITO, ERMINIA DI BARTOLOMEO and LORENZO AGUZZOLI
    Anticancer Research February 2021, 41 (2) 937-948; DOI: https://doi.org/10.21873/anticanres.14847
  • You have access
    Elevated Free Triiodothyronine Is Associated With Increased Proliferative Activity in Triple-negative Breast Cancer
    BENJAMIN NISMAN, TANIR M. ALLWEIS, EINAT CARMON, LUNA KADOURI, BELLA MALY, OFRA MAIMON, AMICHAY MEIROVITZ and TAMAR PERETZ
    Anticancer Research February 2021, 41 (2) 949-954; DOI: https://doi.org/10.21873/anticanres.14848
  • You have access
    Relevance of Laparoscopic Surgery for Ovarian Cancer in Well-selected Patients: A Propensity-matched Comparison With Laparotomy
    FLORIANE JOCHUM, GABRIELLE AUBRY, MADELEINE PELLERIN, CAMILLE BILLARD, EMILIE FALLER, THOMAS BOISRAME, LISE LECOINTRE and CHERIF AKLADIOS
    Anticancer Research February 2021, 41 (2) 955-965; DOI: https://doi.org/10.21873/anticanres.14849
  • You have access
    Survival and Prognostic Nomogram for Primary Gastrointestinal Melanoma (PGIM): A Population-based Study
    HARUN BADAKHSHI, ZI-MING WANG, REN-JIE LI, MAHMOUD ISMAIL and DAVID KAUL
    Anticancer Research February 2021, 41 (2) 967-974; DOI: https://doi.org/10.21873/anticanres.14850
  • You have access
    Prediction Model for Gastric Cancer With DNA Mismatch Repair Deficiency
    OKIHIDE SUZUKI, TATSURO YAMAGUCHI, MINORU FUKUCHI, ERITO MOCHIKI, TOMIO ARAI, KIWAMU AKAGI and HIDEYUKI ISHIDA
    Anticancer Research February 2021, 41 (2) 975-982; DOI: https://doi.org/10.21873/anticanres.14851
  • You have access
    Epidermal Growth Factor Receptor and its Oncogenic EGFRvIII Variant in Benign and Malignant Brain Tumors
    MICHAL KIELBUS, RADOSLAW ROLA, BOZENA JAROSZ, WITOLD JELENIEWICZ, MAREK CYBULSKI, AGNIESZKA STENZEL-BEMBENEK, ARKADIUSZ PODKOWINSKI, JOLANTA SMOK-KALWAT, KRZYSZTOF POLBERG, TOMASZ TROJANOWSKI, DAWID STEFANIUK and ANDRZEJ STEPULAK
    Anticancer Research February 2021, 41 (2) 983-991; DOI: https://doi.org/10.21873/anticanres.14852
  • You have access
    Laparoscopic Surgery for Colorectal Cancer in Patients on Hemodialysis: A Propensity Score-matched Analysis
    NAO OBARA, YASUMITSU HIRANO, TOSHIMASA ISHII, HIROKA KONDO, KIYOKA HARA, LIMING WANG, MASAHIRO ASARI, MISATO ITO and SHIGEKI YAMAGUCHI
    Anticancer Research February 2021, 41 (2) 993-997; DOI: https://doi.org/10.21873/anticanres.14853
  • You have access
    Lower Genital Tract Melanomas: Staging, Predictors of Outcome, and New Therapeutic Options
    EVA KATHARINA EGGER, MATTHIAS B. STOPE, FLORIAN RECKER, DOMINIQUE KONSGEN, JENNIFER LANDSBERG, ANNE FROHLICH, ALINA ABRAMIAN and ALEXANDER MUSTEA
    Anticancer Research February 2021, 41 (2) 999-1004; DOI: https://doi.org/10.21873/anticanres.14854
  • You have access
    Prognostic Factors for Gastric Cancer Patients With One Stage IV Factor who Underwent Conversion Surgery
    YOTA SHIMODA, HIROHITO FUJIKAWA, KEISUKE KOMORI, HAYATO WATANABE, KAZUKI KANO, TAKANOBU YAMADA, MANABU SHIOZAWA, SOICHIRO MORINAGA, KENJI KATSUMATA, AKIHIKO TSUCHIDA, TAKASHI OGATA and TAKASHI OSHIMA
    Anticancer Research February 2021, 41 (2) 1005-1012; DOI: https://doi.org/10.21873/anticanres.14855
  • You have access
    Intraoperative Shear Wave Elastography as a Quantitative Predictor of Pancreatic Fibrosis and Exocrine Function
    YUSUKE WADA, TAKESHI AOKI, AKIRA FUJIMORI, NOBUYUKI OHIKE, TOMOTAKE KOIZUMI, TOMOKAZU KUSANO, KAZUHIRO MATSUDA, KOJI NOGAKI, YOSHIHIKO TASHIRO, TOMOKI HAKOZAKI, HIDEKI SHIBATA, KODAI TOMIOKA, TAKAHITO HIRAI, KAZUHIKO SAITO, TATSUYA YAMAZAKI and MASAHIKO MURAKAMI
    Anticancer Research February 2021, 41 (2) 1013-1019; DOI: https://doi.org/10.21873/anticanres.14856
  • You have access
    Serum Soluble Interleukin-2 Receptor as a Potential Biomarker for Immune-related Adverse Events
    RYO TAKAI, YOHEI FUNAKOSHI, HIROTAKA SUTO, YOSHIAKI NAGATANI, YOSHINORI IMAMURA, MASANORI TOYODA, KIMIKAZU YAKUSHIJIN, NAOMI KIYOTA, KEN-ICHI HARADA, KIMIHIRO YAMASHITA, YOSHIHIRO KAKEJI and HIRONOBU MINAMI
    Anticancer Research February 2021, 41 (2) 1021-1026; DOI: https://doi.org/10.21873/anticanres.14857
  • You have access
    Clinical Outcome of the Patients With Brain Metastasis from Soft Tissue Sarcomas
    TOSHIYUKI TAKEMORI, TERUYA KAWAMOTO, MASAYUKI MORISHITA, HITOMI HARA, NAOMASA FUKASE, YOHEI KAWAKAMI, SHUICHI FUJIWARA, KAZUMICHI KITAYAMA, SHUNSUKE YAHIRO, TOMOHIRO MIYAMOTO, TAKUYA FUJIMOTO, IKUO FUJITA, YUTAKA MIFUNE, YUICHI HOSHINO, KENICHIRO KAKUTANI, TOMOYUKI MATSUMOTO, TAKEHIKO MATSUSHITA, TAKAHIRO NIIKURA, RYOSUKE KURODA and TOSHIHIRO AKISUE
    Anticancer Research February 2021, 41 (2) 1027-1034; DOI: https://doi.org/10.21873/anticanres.14858
  • You have access
    Discrepancy Between Clinical Diagnosis and Whole-exome Sequencing-based Clonality Analysis of Synchronous Multiple Oral Cancers
    NAOTO NISHII, YOSUKE HIROTSU, NAMI KOIDA, YUKINOBU TAKAHASHI, YUKI TAKAGAWA, KENJI AMEMIYA, TOSHIO OYAMA, HITOSHI MOCHIZUKI, EMI FURUSAWA-NISHII, HIROYUKI HARADA and MASAO OMATA
    Anticancer Research February 2021, 41 (2) 1035-1040; DOI: https://doi.org/10.21873/anticanres.14859
  • You have access
    Effectiveness of Salvage Knee Rotationplasty on Sarcoma Around the Knee in Adolescents and Young Adults
    HIDEYUKI KINOSHITA, TSUKASA YONEMOTO, HIROTO KAMODA, YOKO HAGIWARA, TOSHINORI TSUKANISHI, MASAHIRO INOUE, FUMIHIDE TERAKAWA, SEIJI OHTORI and TAKESHI ISHII
    Anticancer Research February 2021, 41 (2) 1041-1046; DOI: https://doi.org/10.21873/anticanres.14860
  • You have access
    A New Model to Improve the Prediction of Prognosis of Endometrial Carcinoma by Combining Traditional Classification With the Presence of Tumor-infiltrating Lymphocytes
    MORIKAZU MIYAMOTO, TAIRA HADA, HIROKI ISHIBASHI, HIDEKI IWAHASHI, SOICHIRO KAKIMOTO, RIE SUZUKI, TAKAHIRO SAKAMOTO, HIROKO MATSUURA, HITOSHI TSUDA and MASASHI TAKANO
    Anticancer Research February 2021, 41 (2) 1047-1053; DOI: https://doi.org/10.21873/anticanres.14861
  • You have access
    Salvage Therapy After Regorafenib or Trifluridine/Tipiracil Treatment of Metastatic Colorectal Cancer: A Conditional Landmark Analysis
    MASAYUKI NAKASHIMA, MASATO TAKEUCHI, SHIRO TANAKA and KOJI KAWAKAMI
    Anticancer Research February 2021, 41 (2) 1055-1062; DOI: https://doi.org/10.21873/anticanres.14862
  • You have access
    Impact of the Relative Dose Intensity of Neoadjuvant Chemotherapy With Anthracycline Followed by Taxane on the Survival of Patients With Human Epidermal Growth Factor Receptor 2-negative Breast Cancer: The JONIE1 Study
    AKIMITSU YAMADA, KYOKO NAKAZAWA, KOHEI AKAZAWA, KAZUTAKA NARUI, ITARU ENDO, YOSHIE HASEGAWA, NORIO KOHNO, TAKASHI ISHIKAWA and THE JONIE STUDY GROUP
    Anticancer Research February 2021, 41 (2) 1063-1068; DOI: https://doi.org/10.21873/anticanres.14863
  • You have access
    Patient Age and Long-term Survival in Colorectal Cancer Patients Who Undergo Emergency Surgery
    KEISUKE KOSUMI, KOSUKE MIMA, ATSUSHI MORITO, SHINSEI YUMOTO, TAKASHI MATSUMOTO, MITSUHIRO INOUE, TAKAO MIZUMOTO, TATSUO KUBOTA, NOBUTOMO MIYANARI and HIDEO BABA
    Anticancer Research February 2021, 41 (2) 1069-1076; DOI: https://doi.org/10.21873/anticanres.14864
  • You have access
    Clinical Significance of Past History of Breast Cancer Screening for the Prognosis of Triple Negative Breast Cancer
    SHINGO INOUE, HIROMICHI KAWAIDA, RYO SAITO, YUKO NAKAYAMA, MASATO OHMORI, AYAKO KIMURA, KATSUTOSHI SHODA, SHINJI FURUYA, NAOHIRO HOSOMURA, HIDENORI AKAIKE, YOSHIHIKO KAWAGUCHI, HIDETAKE AMEMIYA, MAKOTO SUDO, HIROSHI KONO and DAISUKE ICHIKAWA
    Anticancer Research February 2021, 41 (2) 1077-1082; DOI: https://doi.org/10.21873/anticanres.14865
  • You have access
    Clinical Applicability of the Proliferation Marker Thymidine Kinase 1 in Head and Neck Cancer Patients
    AMICHAY MEIROVITZ, MENACHEM GROSS, VERA LEIBOVICI, KIM SHEVA, AHARON POPOVZER and VIVIAN BARAK
    Anticancer Research February 2021, 41 (2) 1083-1087; DOI: https://doi.org/10.21873/anticanres.14866
  • You have access
    BP180 Is a Prognostic Factor in Head and Neck Squamous Cell Carcinoma
    XUE MENG, FUMIHIKO MATSUMOTO, TAISUKE MORI, NAMI MIURA, YOSHINORI INO, KAORU ONIDANI, KENYA KOBAYASHI, YUSUKE MATSUZAKI, SEIICHI YOSHIMOTO, KATSUHISA IKEDA and KAZUFUMI HONDA
    Anticancer Research February 2021, 41 (2) 1089-1099; DOI: https://doi.org/10.21873/anticanres.14867
  • You have access
    Prognostic Reappraisal of Postoperative Carcinoembryonic Antigen in T1-2N0 Colorectal Cancer
    GUANGZHE PIAN, JUN SANG SHIN, SUNSEOK YOON and SEUNG YEOP OH
    Anticancer Research February 2021, 41 (2) 1101-1110; DOI: https://doi.org/10.21873/anticanres.14868
  • You have access
    ABSTRACTS OF THE 8TH INTERNATIONAL CONFERENCE ON ADVANCES IN HEMATOLOGY AND ONCOLOGY (ICAHO2020)
    The Binaytara Foundation
    Anticancer Research February 2021, 41 (2) 1111-1122; DOI: https://doi.org/10.21873/anticanres.14869
Back to top
PreviousNext

In this issue

Anticancer Research: 41 (2)
Anticancer Research
Vol. 41, Issue 2
February 2021
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)

Issue highlights

  • The Acute Phase Protein Hepcidin Is Cytotoxic to Human and Mouse Myeloma Cells
  • Inhibition of Invasion by Polyphenols from Citrus Fruit and Berries in Human Malignant Glioma Cells In Vitro
  • Serological Biomarker Test (GastroPanel®) in the Diagnosis of Functional Gastric Disorders, Helicobacter pylori and Atrophic Gastritis in Patients Examined for Dyspeptic Symptoms
  • Metformin Associates With Aggressive Features of Endometrial Cancer in Women With Type 2 Diabetes
  • YYB-101, a Humanized Antihepatocyte Growth Factor Monoclonal Antibody, Inhibits Ovarian Cancer Cell Motility and Proliferation
Sign up for alerts

Jump to

  • Reviews
  • Experimental Studies
  • Clinical Studies
  • Top Topics
  • Most Cited
  • Most Read
Loading
Role of Resveratrol in Prevention and Therapy of Cancer: Preclinical and Clinical Studies
The Association of Solar Ultraviolet B (UVB) with Reducing Risk of Cancer: Multifactorial Ecologic Analysis of Geographic Variation in Age-adjusted Cancer Mortality Rates
Epithelial−Mesenchymal Transition in EGFR-TKI Acquired Resistant Lung Adenocarcinoma
Vitamin D Supplement Doses and Serum 25-Hydroxyvitamin D in the Range Associated with Cancer Prevention
Anticancer Research

© 2023 Anticancer Research

Powered by HighWire